2008
DOI: 10.1016/j.jconrel.2007.09.013
|View full text |Cite
|
Sign up to set email alerts
|

Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivatives

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
581
0
4

Year Published

2008
2008
2016
2016

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 954 publications
(600 citation statements)
references
References 104 publications
1
581
0
4
Order By: Relevance
“…In many studies to date, the influence of changing numerous process parameters -such as the amount of polymer and drug used, the time for preparation, and the selected excipients (different emulsifier or release modifier) -on particles produced via the double emulsion method has been described (Buske et al, 2012;Corrigan and Li, 2009;Cruz et al, 2011;Feczkó et al, 2011;Mundargi et al, 2008). However, for comparison of the potential of a polymer to act as an encapsulation material it is of utmost importance to keep the majority of process parameters unchanged.…”
Section: Results and Disussionmentioning
confidence: 99%
“…In many studies to date, the influence of changing numerous process parameters -such as the amount of polymer and drug used, the time for preparation, and the selected excipients (different emulsifier or release modifier) -on particles produced via the double emulsion method has been described (Buske et al, 2012;Corrigan and Li, 2009;Cruz et al, 2011;Feczkó et al, 2011;Mundargi et al, 2008). However, for comparison of the potential of a polymer to act as an encapsulation material it is of utmost importance to keep the majority of process parameters unchanged.…”
Section: Results and Disussionmentioning
confidence: 99%
“…Microparticles of PLGA have been widely studied for their use as drug and antigen delivery systems [3], [31] and [6]. These particulate systems are able to deliver drugs or antigens such as DNA, proteins, and peptides over prolonged periods of time, and induce strong immune responses against encapsulated antigens [13], which makes them attractive candidates for vaccine development.…”
Section: Discussionmentioning
confidence: 99%
“…Novel approaches include use of polymeric NP (Richardson et al, 2001) and the careful choice of the encapsulating polymer provides a biodegradable and biocompatible formulation (Mundargi et al, 2008). Biodegradable polyesters are ideal precursors for making NP that encapsulate smaller peptides and proteins, leading to improved pharmacokinetic profiles and reduced frequency of administration (Chan et al, 2009), but they are not without difficulty (Takenaga et al, 2002).…”
Section: Introductionmentioning
confidence: 99%